Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Numinus Wellness Inc (NUMI.TO)

Numinus Wellness Inc (NUMI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 30,452
  • Shares Outstanding, K 320,552
  • Annual Sales, $ 23,180 K
  • Annual Income, $ -30,256 K
  • 60-Month Beta 1.59
  • Price/Sales 1.07
  • Price/Cash Flow N/A
  • Price/Book 3.01
Trade NUMI.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.11
  • Most Recent Earnings $-0.02 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0850 +23.53%
on 03/22/24
0.1250 -16.00%
on 03/07/24
-0.0050 (-4.55%)
since 02/28/24
3-Month
0.0850 +23.53%
on 03/22/24
0.2000 -47.50%
on 01/08/24
-0.0050 (-4.55%)
since 12/28/23
52-Week
0.0850 +23.53%
on 03/22/24
0.2750 -61.82%
on 05/30/23
-0.0800 (-43.24%)
since 03/28/23

Most Recent Stories

More News
Numinus Wellness Submits Clinical Trial Application

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0763 (+9.00%)
NUMI.TO : 0.1050 (+10.53%)
Numinus Wellness Provides Corporate Update

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0763 (+9.00%)
NUMI.TO : 0.1050 (+10.53%)
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

MNMD : 9.40 (-1.05%)
NUMIF : 0.0763 (+9.00%)
NUMI.TO : 0.1050 (+10.53%)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

CMPS : 8.32 (-12.42%)
SEEL : 0.5910 (-7.56%)
ATAI : 1.9700 (+10.06%)
MNMD : 9.40 (-1.05%)
NUMI.TO : 0.1050 (+10.53%)
NUMIF : 0.0763 (+9.00%)
Stocks in play: Numinus Wellness Inc.

Announced the closing of its previously announced "bought deal" public offering of 50,000,000 units ...

NUMI.TO : 0.1050 (+10.53%)
Numinus Wellness Inc. Closes $6 Million Bought Deal Public Offering

/CNW/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI), a mental health care company advancing traditional and innovative behavioral health treatments with a...

NUMI.TO : 0.1050 (+10.53%)
Stocks in play: Numinus Wellness Inc.

Congratulates the Multidisciplinary Association for Psychedelic Studies ("MAPS") for incubating the ...

NUMI.TO : 0.1050 (+10.53%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

CMPS : 8.32 (-12.42%)
SEEL : 0.5910 (-7.56%)
ATAI : 1.9700 (+10.06%)
MNMD : 9.40 (-1.05%)
NUMI.TO : 0.1050 (+10.53%)
NUMIF : 0.0763 (+9.00%)
Numinus Wellness Inc. Congratulates Lykos Therapeutics on FDA Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI), a mental health care company advancing traditional and innovative behavioral health...

NUMI.TO : 0.1050 (+10.53%)
Numinus Wellness Divests of Holdings in Alto Neuroscience Inc.

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMI.TO : 0.1050 (+10.53%)
NUMIF : 0.0763 (+9.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.1183
2nd Resistance Point 0.1117
1st Resistance Point 0.1083
Last Price 0.1050
1st Support Level 0.0983
2nd Support Level 0.0917
3rd Support Level 0.0883

See More

52-Week High 0.2750
Fibonacci 61.8% 0.2024
Fibonacci 50% 0.1800
Fibonacci 38.2% 0.1576
Last Price 0.1050
52-Week Low 0.0850

See More

Business Summary

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar